CIK: 1852291 - Address: C/O Mourant Governance Services (Cayman), 94 Solaris Avenue, Camana Bay, Grand Cayman, E9 KY1-1108
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/20/24 17:25
6/17/24
BGNEBeigene, Ltd.HealthDrugPharmaceutical PreparationsWang LaiE9OGlobal HS.m-368157.270-201,797D
6/27/23 17:24
6/26/23
BGNEBeigene, Ltd.HealthDrugPharmaceutical PreparationsWang LaiE9OGlobal HS-202181.920-101,658D
6/20/23 18:53
6/20/23
BGNEBeigene, Ltd.HealthDrugPharmaceutical PreparationsWang LaiE9OGlobal HS.d-255192.420-101,673D
6/9/23 17:46
6/7/23
BGNEBeigene, Ltd.HealthDrugPharmaceutical PreparationsWang LaiE9OGlobal HS-104224.740001,556D
6/28/22 17:32
6/27/22
BGNEBeigene, Ltd.HealthDrugPharmaceutical PreparationsWang LaiE9OGlobal HS-81177.330001,562D
6/22/22 17:47
6/17/22
BGNEBeigene, Ltd.HealthDrugPharmaceutical PreparationsWang LaiE9OGlobal HS.m-170145.350-101,443D
6/8/22 17:43
6/6/22
BGNEBeigene, Ltd.HealthDrugPharmaceutical PreparationsWang LaiE9OGlobal HS-94142.000-101,458D
5/19/22 16:39
5/17/22
BGNEBeigene, Ltd.HealthDrugPharmaceutical PreparationsWang LaiE9OGlobal HM.d4,0263.2601,2345301,467D
6/30/21 16:48
6/28/21
BGNEBeigene, Ltd.HealthDrugPharmaceutical PreparationsWang LaiE9OGlobal HS-165362.48000233D
6/21/21 16:47
6/18/21
BGNEBeigene, Ltd.HealthDrugPharmaceutical PreparationsWang LaiE9OGlobal HS.d-266331.150-10239D
6/9/21 16:46
6/7/21
BGNEBeigene, Ltd.HealthDrugPharmaceutical PreparationsWang LaiE9OGlobal HS-232354.260-10195D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact